Profile

Jeffrey Rogers, M.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Jeffrey Rogers, M.D.

Professor,

Clinical Specialties

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-0548
Department: 336-716-6371

Email: jerogers@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., University of Pennsylvania , 1986
  • M.D., Albert Einstein College of Medicine , 1990
  • Residency, Montefiore Hosp/Med Ctr, 1995
  • Fellowship, Transplant Surgery, University of Pittsburgh Schoo, 1996
  • Fellowship, Transplantation Immunology, University of Pittsburgh Schoo, 1997
  • Fellowship, Transplant Surgery, University of Pittsburgh Schoo, 1999

NPI Number

  • 1073598140
Jeffrey Rogers, M.D.

Doctor Rating

No Rating Available
Why No Ratings?

Jeffrey Rogers, M.D.

Professor, Surgery, General
Institute for Regenerative Medicine

Research Interests

transplantation

Contact Information

Academic: 336-716-6371 | Department: 336-716-6371

Email: jerogers@wakehealth.edu

Recent Publications

Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ. Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Clin Transplant. 2014;28(1):16-26.

Al-shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R. Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Am J Transplant. 2014;14(Suppl 2):72.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Am J Transplant. 2014;14(Suppl 2):74-75.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Effect of donor obesity on outcomes in expanded criteria donor kidney transplantation [abstract]. Am J Transplant. 2014;14(Suppl 2):74.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Does high recipient BMI influence outcomes in deceased donor kidney transplantation? A paired donor kidney analysis [abstract]. Am J Transplant. 2014;14(Suppl 2):74.

Stratta RJ, Farney AC, Rogers J, Orlando G. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Expert Rev Clin Immunol. 2014;10(1):117-132.

Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Transplantation. 2014;98(Suppl 1):631.

Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R. Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Transplantation. 2014;98(Suppl 1):855.

Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R. Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Transplantation. 2014;98(Suppl 1):864.

Farney A, Rogers J, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R. 7 year results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Transplantation. 2014;98(Suppl 1):9.

Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta RJ. Dual kidney transplants from marginal donors: double or nothing [abstract]. Am J Transplant. 2013;13(Suppl 2):72.

Farooq U, Al-Shraideh Y, Al-Geizawi S, Orlando G, Rogers J, Farney A, Stratta RJ. Effect of donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants [abstract]. Am J Transplant. 2013;13(Suppl 2):73-74.

Farooq U, Farney AC, Rogers J, Orlando G, Al-Shraideh Y, Stratta RJ. A decade of experience with deceased donor kidney transplantation in recipients over age 75 [abstract]. Am J Transplant. 2013;13(Suppl 2):73.

Farooq U, Al-Shraideh Y, Orlando G, Rogers J, Farney A, Stratta RJ. Influence of recipient age on outcomes in paired kidney transplantation [abstract]. Am J Transplant. 2013;13(Suppl 2):74.

Farooq U, Rogers J, Al-Shraideh Y, Orlando G, Farney A, Stratta RJ. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Am J Transplant. 2013;13(Suppl 2):74.

Orlando G, Booth C, Wang Z, Petrosyan A, Ross CL, Iskandar S, Rogers J, Farney AC, Delario G, Stratta RJ, Perin L, Soker S. Discarded kidneys as a platform for renal bioengineering and regeneration investigations [abstract]. Am J Transplant. 2013;13(Suppl 2):78.

Farney AC, Rogers J, Orlando G, al-Geizawi S, Buckley M, Farooq U, al-Shraideh Y, Stratta RJ. Evolving experience using kidneys from deceased donors with terminal acute kidney injury.. J Am Coll Surg. 2013;216(4):645-656.

Farooq U, Farney A, Rogers J, Orlando G, Al-Shraideh Y, Stratta R. A decade of experience with deceased donor kidney transplantation in recipients over age 75 [abstract]. Am J Transplant. 2013;13(Suppl 5):521.

Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Gautreaux M, Winfrey S, Uloko V, Iskandar S, Brim E, Hairston G, Stratta R. Transplantation of CDC high risk kidneys: a low risk option for a high risk problem [abstract]. Am J Transplant. 2013;13(Suppl 5):403.

Al-shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R. Dual kidney transplants from marginal donors: double or nothing [abstract]. Am J Transplant. 2013;13(Suppl 5):484.

Farooq U, Al-Shraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Influence of recipient age on outcomes in paired kidney transplantation [abstract]. Am J Transplant. 2013;13(Suppl 5):484.

Swords DC, Al-Geizawi SM, Farney AC, Rogers J, Burkart JM, Assimos DG, Stratta RJ. Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution. Clin Transplant. 2013;27(2):E199-E205.

Reeves-Daniel AM, Farney AC, Fletcher AJ, Assimos D, Westcott C, Rogers J, Stratta RJ, Rocco MV, Freedman BI. Ethnicity, medical insurance, and living kidney donation. Clin Transplant. 2013;27(4):E498-E503.

Orlando G, Booth C, Wang Z, Totonelli G, Ross CL, Moran E, Salvatori M, Maghsoudlou P, Turmaine M, Delario G, Al-Shraideh Y, Farooq U, Farney AC, Rogers J, Iskandar SS, Burns A, Marini FC, De Coppi P, Stratta RJ, Soker S. Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies. Biomaterials. 2013;34(24):5915-5925.

Rogers J, Farney A, Iskandar S, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Gautreaux M, Stratta RJ. Similar results with solitary pancreas compared to simultaneous kidney-pancreas transplantation in the new millennium [abstract]. Transplantation. 2013;96(6 Suppl):S11.

Stratta RJ, Rogers J, Hart L, Doares W, Kaczmorski S, Reeves-Daniel A, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Iskandar S, Farney A. 5 year results of a prospective randomized single center study of alemtuzumab compared to rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation [abstract]. Transplantation. 2013;96(6 Suppl):S86.

Stratta RJ, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Rogers J. Single center analysis of mortality in 202 consecutive pancreas transplants [abstract]. Transplantation. 2013;96(6 Suppl):S87.

Farney AC, Rogers J, Stratta RJ. Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention. Curr Opin Organ Transplant. 2012;17(1):87-92.

Orlando G, Wood KJ, De Coppi P, Baptista PM, Binder KW, Bitar KN, Breuer C, Burnett L, Christ G, Farney A, Figliuzzi M, Holmes JH IV, Koch K, Macchiarini P, Mirmalek Sani S-H, Opara E, Remuzzi A, Rogers J, Saul JM, Seliktar D,. Regenerative medicine as applied to general surgery. Ann Surg. 2012;255(5):867-880.

Chen A, Farney A, Hart L, Doares W, Spainhour L, Kaczmorski S, Stratta R, Rogers J, Lin J-J. Alemtuzumab versus antithymocyte globulin as induction in pediatric renal transplantation: our single-center experience [abstract]. Am J Transplant. 2012;12(Suppl 3):316-317.

Doares W, Chen A, Lin J-J, Hart L, Spainhour L, Kaczmorski S, Rogers J, Stratta R, Farney A. Infectious complications in pediatric renal transplant recipients who received alemtuzumab or rabbit anti-thymocyte globulin induction [abstract]. Am J Transplant. 2012;12(Suppl 3):440-441.

Farney A, Rogers J, Hart L, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R. Long-term results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):56.

Kaczmorski S, Doares W, Winfrey S, Uloko V, McArthur M, Reeves-Daniel A, Ghanta M, Rogers J, Farney A, Stratta R. Breakthrough CMV infection rates are similar using low dose vs. standard dose valganciclovir in high risk D+/R- kidney or kidney/pancreas transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):470.

Reeves-Daniel AM, Farney A, Fletcher A, Assimos DG, Westcott CJ, Ghanta M, Stratta RJ, Rogers J, Rocco MV, Freedman BI. Race, insurance status, and living kidney donation [abstract]. Am J Transplant. 2012;12(Suppl 3):332.

Stratta RJ, Farney A, Al-Geizawi S, Orlando G, Rogers J. Lessons learned from a single center experience with 183 donation after cardiac death deceased donor kidney transplants [abstract]. Am J Transplant. 2012;12(Suppl 3):499-500.

Stratta RJ, Farney A, Reeves-Daniel A, Ghanta M, Orlando G, Rogers J. Proportionate nephron mass according to deceased donor category and type of transplant: influence of delayed graft function and acute rejection [abstract]. Am J Transplant. 2012;12(Suppl 3):500.

McArthur MC, Iskandar S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J. Does alemtuzumab induction and negative flow cytometry crossmatching abrogate the need for early graft biopsies in the setting of delayed graft function? [abstract]. Am J Transplant. 2012;12(Suppl 3):372.

Rogers J, Farney A, Orlando G, Brim E, Hairston G, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Winfrey S, McArthur MC, Uloko V, Stratta R. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Am J Transplant. 2012;12(Suppl 3):246-247.

Winfrey SA, Al-Geizawi S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J. Influence of donor and recipient ethnicity on outcomes following deceased donor kidney transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):524.

Orlando G, Garcia-Arraras JE, Soker T, Booth C, Sanders B, Ross CL, De Coppi P, Farney AC, Rogers J, Stratta RJ. Regeneration and bioengineering of the gastrointestinal tract: current status and future perspectives. Dig Liver Dis. 2012;44(9):714-720.

Brown SB, Kiger DF, Rogers J, Gautreaux MD. DP or not DP? That is the question [abstract]. Hum Immunol. 2012;73(Suppl 1):62.

Segev DL, Veale JL, Berger JC, Hiller JM, Hanto RL, Leeser DB, Geffner SR, Shenoy S, Bry WI, Rogers J, et al. Transporting live donor kidneys for kidney paired donation: initial national results. Am J Transplant. 2011;11(2):356-360.

Algeizawi S, Farney A, Rogers J, Stratta R. Does keeping deceased donor kidneys on machine perfusion for longer time really help? [abstract]. Am J Transplant. 2011;11(Suppl 1):69.

Algeizawi S, Zuckerman J, Farney A, Rogers J, Stratta R. A single center experience utilizing kidneys from deceased donors with low terminal estimated creatinine clearances [abstract]. Am J Transplant. 2011;11(Suppl 1):73.

Algeizawi S, Farney A, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams P, Stratta R. Experience with deceased donor kidney transplantation in patients over age 70: is rationing justified? [abstract]. Am J Transplant. 2011;11(Suppl 1):74.

Algeizawi S, Farney A, Rogers J, Stratta R. Single center analysis of outcomes in 150 consecutive pancreas transplants according to different definitions of 'success' [abstract]. Am J Transplant. 2011;11(Suppl 1):90.

Singh RP, Farney AC, Rogers J, Zuckerman J, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta RJ. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant. 2011;25(2):255-264.

Farney AC, Hines MH, al-Geizawi S, Rogers J, Stratta RJ. Lessons learned from a single center's experience with 134 donation after cardiac death donor kidney transplants. J Am Coll Surg. 2011;212(4):440-453.

Orlando G, Baptista P, Birchall M, De Coppi P, Farney A, Opara E, Rogers J, Stratta RJ, Atala A, Soker S, et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int. 2011;24(3):223-232.

Rees M, Kopke J, Pelletier R, Chan L, Melton L, Rogers J, Pankewycz O, Taber T, Nibhanupudy B, Young C, et al. Report from an 80 transplant center multi-regional kidney paired donation program [abstract]. Am J Transplant. 2011;11(Suppl 2):483-484.

Rees M, Chan L, Fabrega A, Rogers J, Pankewycz O, Taber T, Nibhaunpudy B, Leichtman A, Van Buren C, Young C, et al. Fifty NEAD chain kidney transplants [abstract]. Am J Transplant. 2011;11(Suppl 2):313.

Al-Geizawi S, Farney A, Rogers J, Stratta R. Evolving experience utilizing kidneys from deceased donors with terminal acute kidney injury [abstract]. Am J Transplant. 2011;11(Suppl 2):223.

Algeizawi S, Farney A, Rogers J, Gautreaux M, Doares W, Kaczmorski S, Winfrey S, Ghanta M, Reeves-Daniel A, Adams P, Stratta R. Effect of high donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants (DDKT) [abstract]. Am J Transplant. 2011;11(Suppl 2):228.

Kaczmorski S, Doares W, Al-Geizawi S, Gautreaux M, Reeves-Daniel A, Adams P, Ghanta M, Rogers J, Farney A, Stratta R. Are HIV-positive patients at higher risk for BK viral infection following kidney transplantation? [abstract]. Am J Transplant. 2011;11(Suppl 2):259.

Ghanta M, Russell GB, Farney A, Rogers J, Geizawi SA [sic] [Al-Geizawi S], Doares W, Kaczmorski S, Reeves-Daniels A [sic] [Reeves-Daniel A], Adams P, Stratta RJ. Risk factors for early BK virus nephropathy [abstract]. Am J Transplant. 2011;11(Suppl 2):261.

Gautreaux MD, Kiger DF, Winfrey SC, Farney AF [sic] [Farney AC], Rogers J, Beane KN, Victor B, Stewart JW, Stratta RJ. Incorporating a urinary biomarker assay into clinical laboratory practice [abstract]. Am J Transplant. 2011;11(Suppl 2):270.

Rogers J, Farney A, Al-Geizawi S, Doares W, Kaczmorski S, Winfrey S, Gautreaux M, Hart L, Iskandar S, Adams P, Hairston G, Stratta R. Simultaneous kidney-pancreas transplantation in African-American recipients: alemtuzumab versus rATG induction [abstract]. Am J Transplant. 2011;11(Suppl 2):436.

Doares W, Kaczmorski S, Williamson J, Al-Geizawi S, Gautreux M [sic] [Gautreaux M], Reeves-Daniel A, Adams P, Rogers J, Farney A, Stratta R. Millions of dollars baby: is use of IVIG to prevent rejection in sensitized renal and pancreas transplant recipients effective? [abstract]. Am J Transplant. 2011;11(Suppl 2):450-451.

Rogers J, Iskandar S, Farney A, Al-Geizawi S, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Adams P, Stratta R. Long-term outcomes of solitary pancreas transplantation: do surveillance pancreas biopsies level the playing field? [abstract]. Am J Transplant. 2011;11(Suppl 2):431.

Anderson KT, Hart L, Hairston G, McPherson G, Stratta R, Rogers J, Farney A. Simultaneous kidney pancreas transplant recipients have similar perceived physical health quality of life as non-diabetic kidney transplant recipients at 1 and 2 years [abstract]. Am J Transplant. 2011;11(Suppl 2):434.

Al-Geizawi S, Farney A, Rogers J, Reeves-Daniel A, Ghanta M, Winfrey S, Gautreaux M, Doares W, Kaczmorski S, Adams P, Stratta R, et al. 70 deceased donor kidney transplants in patients over age 70: is 70 the new 50? [abstract]. Am J Transplant. 2011;11(Suppl 2):241.

Rogers J, Farney AC, Al-Geizawi S, Iskandar SS, Doares W, Gautreaux MD, Hart L, Kaczmorski S, Reeves-Daniel A, Winfrey S, Ghanta M, Adams PL, Stratta RJ. Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rev Diabet Stud. 2011;8(1):17-27.

Singh RP, Farney AC, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Doares W, Iskandar S, Adams P, Stratta RJ. Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation. Clin Transplant. 2011;25(4):E437-E446.

Kaczmorski S, Doares W, Winfrey S, Al-Geizawi S, Farney A, Rogers J, Stratta R. Gout and transplantation: new treatment option--same old drug interaction [letter]. Transplantation. 2011;92(3):e13-e14.

Reeves-Daniel A, Bailey A, Assimos D, Westcott C, Adams PL, Hartmann EL, Rogers J, Farney AC, Stratta RJ, Daniel K, Freedman BI. Donor-recipient relationships in African American vs. Caucasian live kidney donors. Clin Transplant. 2011;25(5):E487-E490.

Beane KN, Stewart JW, Kiger DF, Rogers J, Gautreaux MD. A urinary biomarker assay in clinical practice [abstract]. Hum Immunol. 2011;72(Suppl 1):S67.

Gautreaux MD, Kiger DF, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Al-Gezawi SM, Stratta RJ. Gauging the guess: comparing virtual crossmatching to the real thing [abstract]. Am J Transplant. 2010;10(Suppl 4):190.

Algeizawi SMT, Singh RP, Zuckerman J, Requarth J, Farney AC, Rogers J, Taussig J, Stratta RJ. Allograft nephrectomy following kidney transplantation: experience with pre-operative angiographic kidney embolization [abstract]. Am J Transplant. 2010;10(Suppl 4):251.

Reeves-Daniel AM, Hartmann EL, Bailey A, Westcott C, Assimos DG, Adams PL, Rogers J, Farney A, Stratta RJ, Daniel KR. The effect of donor-recipient relationship on African American and Caucasian live kidney donors [abstract]. Am J Transplant. 2010;10(Suppl 4):274.

Farney AC, Rogers J, Al-Geizawi S, Reeves-Daniel A, Hartmann E, Adams P, Gautreaux M, Winfrey S, Iskandar S, Stratta R, et al. Infection or rejection: chicken or egg? [abstract]. Am J Transplant. 2010;10(Suppl 4):320.

Al-Geizawi S, Hartmann E, Farney A, Rogers J, Reeves-Daniel A, Winfrey S, Gautreaux M, Iskandar S, Adams P, Stratta R, et al. Experience with deceased donor kidney transplantation in patients over age 70: better late than never! [abstract]. Am J Transplant. 2010;10(Suppl 4):335-336.

Algeizawi SMT, Farney AC, Rogers J, Stratta R. Does keeping deceased donor kidneys on pulsatile perfusion for longer time really help? [abstract]. Am J Transplant. 2010;10(Suppl 4):440.

Al-Geizawi S, Zuckerman J, Farney A, Rogers J, Stratta R. A single center experience utilizing kidneys from deceased donors with low terminal estimated creatinine clearances [abstract]. Am J Transplant. 2010;10(Suppl 4):444.

Rogers J, Farney A, Iskandar S, Reeves-Daniel A, Hartmann E, Al-Geizawi S, Winfrey S, Gautreaux M, Adams P, Stratta R, et al. Baseline biopsies of live donor renal allografts: 'you can observe a lot just by watching' [abstract]. Am J Transplant. 2010;10(Suppl 4):535.

Rees MA, Reece LJ, Chan L, Melton L, Rogers J, Young CJ. Overcoming financial hurdles to funding paired exchange transplants by the creation of a sustainable funding mechanism [abstract]. Am J Transplant. 2010;10(Suppl 4):78.

Rees MA, Kopke JE, Pelletier RP, Segev DL, Fabrega AJ, Rogers J, Pankewycz OG, Roth AE, Taber TE, Unver MU, et al. Six non-simultaneous extended altruistic donor (NEAD) chains [abstract]. Am J Transplant. 2010;10(Suppl 4):275.

Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transplant. 2010;24(4):433-449.

Reeves-Daniel A, Freedman BI, Assimos D, Hartmann EL, Bleyer A, Adams PL, Westcott C, Stratta RJ, Rogers J, Farney AC, Daniel KR. Short-term renal outcomes in African American and Caucasian donors following live kidney donation. Clin Transplant. 2010;24(5):717-722.

Fridell JA, Rogers J, Stratta RJ. Donor management and selection in pancreas transplantation In: Hakim NS, Stratta RJ, Gray D, Friend P, Colman A, eds Pancreas, islet and stem cell transplantation for diabetes. 2nd ed. New York: Oxford University Press, USA;2010: 63-84.

Al-Geizawi SMT, Farney AC, Rogers J, Assimos D, Requarth JA, Doares W, Winfrey S, Stratta RJ. Renal allograft failure due to emphysematous pyelonephritis: successful non-operative management and proposed new classification scheme based on literature review. Transpl Infect Dis. 2010;12(6):543-550.

Stratta RJ, Doares W, Farney AC, Rogers J, Hart L. Randomized prospective trial of depleting antibody induction in kidney and pancreas transplantation: infectious complications [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():O17.01.

Stratta RJ, Al-Geizawi S, Hartmann EL, Farney AC, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams PL. Experience with deceased donor kidney transplantation in patients over age 70: better late than never [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():P39.58.

Stratta RJ, Al-Geizawi S, Zuckerman J, Farney AC, Rogers J. Recovered deceased donor kidneys with low estimated terminal creatinine clearance values should not be discarded [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():P39.59.

Stratta RJ, Al-Geizawi S, Farney AC, Rogers J. Lessons learned from a single center experience with 107 donation after cardiac death deceased donor kidney transplants [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():P39.02.

Farney AC, Doares W, Kaczmorski S, Rogers J, Stratta RJ. Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA. Immunotherapy. 2010;2(6):879-888.

Rees MA, Kopke JE, Pelletier RP, Segev DL, Rutter ME, Fabrega AJ, Rogers J, Pankewyxz OG, Hiller J, Roth AE, et al. A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med. 2009;360(11):1096-1101.

Doares W, Ashcraft E, Singh R, Hart L, Farney A, Hartmann E, Reeves-Daniel A, Rogers J, Adams P, Stratta R. Prospective, randomized, single-center trial of alemtuzumab vs. rabbit anti-thymocyte globulin induction in renal and pancreas transplant: infectious complications update [abstract]. Am J Transplant. 2009;9(Suppl 2):282-283.

Gautreaux MD, Kiger DF, Farney AC, Rogers J, Singh RP, Hartmann EL, Reeves-Daniel AM, Stratta RJ. The virtual crossmatch in kidney transplantation: is that your final answer? [abstract]. Am J Transplant. 2009;9(Suppl 2):488.

Hartmann EL, Doares W, Reeves-Daniel A, Rogers J, Singh R, Hart L, Gautreaux M, Stratta RJ, Farney A. Safety and efficacy of lymphocyte-depleting induction therapy in older transplant recipients: should grandpa receive Campath? [abstract]. Am J Transplant. 2009;9(Suppl 2):675.

Rees M, Segev D, Chan L, Mulgaonkar S, Pankewycz O, Bowers V, VanBuren C, Pelletier R, Nibhunupudy B, Rogers J, et al. Experience with over 50 altruistic and 'bridge' donors involved in never-ending altruistic donor chains and kidney paired donation [abstract]. Am J Transplant. 2009;9(Suppl 2):285-286.

Rees M, Kopke J, Pelletier R, Segev D, Fabrega A, Rogers J, Pankewycz O, Hiller J, Roth A, Sandholm T, et al. Four never-ending altruistic donor chains [abstract]. Am J Transplant. 2009;9(Suppl 2):389.

Rees M, Mulgaokar S, Chan L, Young C, Palekar S, Nibhunupudy B, Pelletier R, Laskow D, Rogers J. Kidney transplant candidate and donor characteristics of 288 incompatible pairs registering for kidney paired donation [abstract]. Am J Transplant. 2009;9(Suppl 2):434.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Singh R, Doares W, Gautreaux M, Adams P, Stratta R. Rejection on early surveillance biopsies after renal transplantation: finding snakes in the grass [abstract]. Am J Transplant. 2009;9(Suppl 2):513.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Singh R, Doares W, Gautreaux M, Adams P, Stratta R. What can reperfusion and 1 month surveillance biopsies tell us about early renal allograft function? [abstract]. Am J Transplant. 2009;9(Suppl 2):588.

Singh R, Farney A, Rogers J, Doares W, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. A randomized, prospective trial of alemtuzumab versus rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation: a single center experience [abstract]. Am J Transplant. 2009;9(Suppl 2):216.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Donor hypertension is the most important pretransplant factor predicting graft loss in kidney transplantation from donation after brain death standard criteria donors [abstract]. Am J Transplant. 2009;9(Suppl 2):222-223.

Singh R, Hines M, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Kiger D, Iskandar S, Adams P, Stratta R. A single center experience using extracorporeal support in donation after cardiac death donors: improved outcomes for renal and extrarenal transplantation [abstract]. Am J Transplant. 2009;9(Suppl 2):234-235.

Singh R, Farney A, Rogers J, Iskandar S, Reeves-Daniel A, Hartmann E, Adams P, Stratta R. Polyoma viral nephropathy--new insights [abstract]. Am J Transplant. 2009;9(Suppl 2):421.

Singh R, Zuckerman J, Farney A, Rogers J, Stratta R. Further expansion of donor organ pool: a single center experience utilizing kidneys from deceased donors with terminal acute renal failure [abstract]. Am J Transplant. 2009;9(Suppl 2):485.

Singh R, Farney A, Iskandar S, Rogers J, Gautreaux M, Hartmann E, Reeves-Daniel A, Adams P, Stratta R. Banff '97 type 2a rejection: the extent of tubulointerstitial inflammation matters [abstract]. Am J Transplant. 2009;9(Suppl 2):509.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Recipient factors affecting outcomes in deceased donor kidney transplantation [abstract]. Am J Transplant. 2009;9(Suppl 2):516.

Singh R, Zuckerman J, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R, et al. A seven year experience with 222 expanded criteria donor kidney transplants at a single center [abstract]. Am J Transplant. 2009;9(Suppl 2):567.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Native end stage renal disease due to immune causes adversely influences outcomes in kidney transplantation from donation after brain death standard criteria donors [abstract]. Am J Transplant. 2009;9(Suppl 2):683-684.

Zuckerman JM, Singh RP, Farney AC, Rogers J, Hines MH, Stratta RJ. Successful kidney transplantation from a donation after cardiac death donor with acute renal failure and bowel infarction using extracorporeal support. Transpl Int. 2009;22(8):798-804.

Farney AC, Rogers J, Singh R, Hartmann E, Hart L, Reeves-Daniel A, Gautreaux M, Iskandar SS, Adams PL, Stratta RJ, et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009;88(6):810-819.

Freedman BI, Nagaraj SK, Lin JJ, Gautreaux MD, Bowden DW, Iskandar SS, Stratta RJ, Rogers J, Hartmann EL, Farney AC, Reeves-Daniel AM. Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. Am J Transplant. 2009;9(10):2435-2440.

Stratta R, Singh R, Farney A, Rogers J, Doares W, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P. A randomized, prospective trial of alemtuzumab versus rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation: a single center experience [abstract]. Transpl Int. 2009;22(Suppl 2):76-77.

Stratta R, Singh R, Hines M, Farney A, Rogers J, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Kiger D, Iskandar S, Adams P. A single center experience using extracorporeal support in donation after cardiac death donors [abstract]. Transpl Int. 2009;22(Suppl 2):102.

Stratta R, Singh R, Zuckerman J, Farney A, Rogers J. A single center experience utilizing kidneys from deceased donors with terminal acute renal failure [abstract]. Transpl Int. 2009;22(Suppl 2):191.

Stratta R, Singh R, Zuckerman J, Farney A, Rogers J, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Iskandar S, Hairston G, Adams P. A seven year experience with 222 expanded criteria donor kidney transplants at a single center [abstract]. Transpl Int. 2009;22(Suppl 2):191.

Stratta RJ, Farney AC, Rogers J. Import pancreas allografts: good from far or far from good? [editorial commentary]. Transplantation. 2009;88(5):622-623.

Zuckerman JM, Singh RP, Farney AC, Rogers J, Stratta RJ. Single center experience transplanting kidneys from deceased donors with terminal acute renal failure. Surgery. 2009;146(4):686-695.

Gautreaux M, Kiger D, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Stratta R. The virtual crossmatch in kidney transplantation: psychic or psychotic? [abstract]. Hum Immunol. 2009;70(Suppl 1):S20.

Farney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta R. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Clin Transplant. 2008;22(1):41-49.

Singh RP, Farney AC, Rogers J, Ashcraft E, Hart L, Doares W, Hartmann EL, Reeves-Daniel A, Adams PL, Stratta RJ. Analysis of bacteremia after pancreatic transplantation with enteric drainage. Transplant Proc. 2008;40(2):506-509.

Singh RP, Rogers J, Farney AC, Hartmann EL, Reeves-Daniel A, Doares W, Ashcraft E, Adams PL, Stratta RJ. Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation?. Transplant Proc. 2008;40(2):510-512.

Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage. Transplant Proc. 2008;40(2):502-505.

Farney AC, Singh RP, Hines MH, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg. 2008;206(5):1028-1037.

Hartmann E, Ashcraft E, Reeves-Daniel A, Rogers J, Doares W, Hart L, Gautreaux M, Stratta R, Farney A. Lymphocyte-depleting induction therapy in aging renal transplant recipients [abstract]. Am J Transplant. 2008;8(Suppl 2):436.

Reeves-Daniel A, Daniel K, Assimos D, Westcott C, Rogers J, Farney A, Stratta R, Hartmann E, Adams P, Bleyer A, Freedman B. Similar short-term renal outcomes among African Americans and caucasians following live kidney donation [abstract]. Am J Transplant. 2008;8(Suppl 2):191.

Rogers J, Pomper G, Singh R, Farney A, Hartmann E, Reeves-Daniel A, Iskandar S, Gautreaux M, Adams P, Stratta R, et al. Blood transfusion after renal transplantation is associated with inferior early outcome [abstract]. Am J Transplant. 2008;8(Suppl 2):369.

Singh RP, Farney A, Rogers J, Zuckerman JM, Gautreaux M, Iskandar S, Adams P, Stratta R. Impact of native end stage renal disease on kidney allograft outcomes: rejection or infection? A multivariate analysis [abstract]. Am J Transplant. 2008;8(Suppl 2):351.

Singh RP, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Expanded versus standard criteria donors in kidney transplantation: does donor and recipient age-matching make a difference? [abstract]. Am J Transplant. 2008;8(Suppl 2):368-369.

Singh RP, Zuckerman JM, Farney A, Rogers J, Hartmann E, Gautreaux M, Reeves-Daniel A, Iskandar S, Adams P, Stratta R. Lack of impact of delayed graft function on post-transplant outcomes in kidney transplantation from donation after cardiac death donors [abstract]. Am J Transplant. 2008;8(Suppl 2):369.

Singh RP, Gautreaux MD, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Kiger DF, Iskandar SS, Adams PL, Stratta RJ. Should kidneys from zero-antigen mismatch expanded criteria donors be shared? [abstract]. Am J Transplant. 2008;8(Suppl 2):392.

Singh RP, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Zuckerman JM, Iskandar SS, Adams PL, Stratta RJ. Multivariate analysis of risk factors for acute rejection and kidney allograft loss according to recipient age [abstract]. Am J Transplant. 2008;8(Suppl 2):522.

Singh RP, Farney A, Rogers J, Ashcraft E, Doares W, Hartmann E, Reeves-Daniel A, Gautreaux M, Adams P, Stratta R. Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation [abstract]. Am J Transplant. 2008;8(Suppl 2):556.

Singh RP, Farney A, Rogers J, Ashcraft E, Hart L, Doares W, Hartmann E, Reeves-Daniel A, Adams P, Stratta R. Natural history of bacterial infection after enteric exocrine and portal venous drainage of pancreas allografts [abstract]. Am J Transplant. 2008;8(Suppl 2):556.

Singh RP, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Risk factors for graft loss in expanded versus standard criteria kidneys: a multivariate analysis [abstract]. Am J Transplant. 2008;8(Suppl 2):600.

Stratta RJ, Farney AC, Rogers J, Singh RP, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Experience with extended donors and recipients in simultaneous kidney-pancreas transplantation [abstract]. Am J Transplant. 2008;8(Suppl 2):200.

Stratta RJ, Singh RP, Farney AC, Rogers J, Hines MH, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Single center experience in kidney and kidney-pancreas transplantation with donation after cardiac death donors with selective use of extracorporeal support [abstract]. Am J Transplant. 2008;8(Suppl 2):367.

Hartmann EL, Ratliff H, Ashcraft E, Reeves-Daniel A, Farney AC, Rogers J, Stratta RJ, Russell GB. Renal outcomes in older recipients of expanded and standard criteria deceased donor kidney transplants [abstract]. J Am Soc Nephrol. 2008;19():686A.

Stratta RJ, Moore PS, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg. 2007;204(5):873-884.

Hartmann E, Stratta R, Ashcraft E, Reeves-Daniel A, Doares W, Moore P, Hart L, Sundberg A, Rogers J, Farney A. Short term outcomes in transplant recipients over age 60 randomized to either campath or thymoglobulin induction therapy [abstract]. Am J Transplant. 2007;7(Suppl 2):523.

Jarrett A, Svejkovsky L, Doares W, Ashcraft E, Farney A, Hartman [sic] E [Hartmann E], Rogers J, Adams P, Stratta R. Influence of a pharmacy-based transplant patient medication assistance program on length of stay (LOS), re-admissions, and costs [abstract]. Am J Transplant. 2007;7(Suppl 2):396.

Gautreaux MD, Kiger DF, Robinson DL, Reeves-Daniel AM, Adams PL, Hartmann EL, Farney AC, Rogers J, Stratta RJ. A positive T-cell flow cytometric crossmatch may not be a contraindication to renal transplant [abstract]. Am J Transplant. 2007;7(Suppl 2):289.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Doares W, Ashcraft E, Gautreaux M, Adams P, Stratta R. Surveillance pancreas biopsies in solitary pancreas transplantation: a shot in the dark? [abstract]. Am J Transplant. 2007;7(Suppl 2):251.

Ashcraft E, Farney A, Moore P, Hartmann E, Rogers J, Doares W, Hart L, Adams P, Stratta R. A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: infectious complications [abstract]. Am J Transplant. 2007;7(Suppl 2):234.

Farney A, Rogers J, Ashcroft E, Hartmann E, Hart L, Doares W, Moore P, Jarrett A, Sundberg A, Adams P, Stratta R. Alemtuzumab versus rabbit antithymocyte globulin induction in kidney and pancreas transplantation: a prospective randomized study [abstract]. Am J Transplant. 2007;7(Suppl 2):233.

Reeves-Daniel A, Daniel K, Alcorn S, Farney A, Rogers J, Wescott C, Assimos D, Stratta R, Adams P, Hartmann E. Impact of ethnicity on living kidney donation [abstract]. Am J Transplant. 2007;7(Suppl 2):218.

Gautreaux MD, Kiger DF, Robinson DL, Reeves-Daniel AM, Adams PL, Hartmann EL, Farney AC, Rogers J, Stratta RJ. A positive T-Cell flow cytometric crossmatch may not be a contraindication to renal transplant [abstract]. Am J Transplant. 2007;7(Suppl 2):289.

Moore PS, Farney AC, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Anderson TK, Adams PL, Stratta RJ, et al. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation. 2007;83(12):1551-1556.

Rogers J, Stratta RJ. The metabolic syndrome as a risk factor in simultaneous kidney-pancreas transplantation. Nat Clin Pract Endocrinol Metab. 2007;3(7):498-499.

Farney AC, Singh RP, Rogers J, Ashcraft E, Doares W, Hartmann EL, Reeves-Daniel A, Gautreaux M, Adams PL, Stratta RJ. Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation [abstract]. Xenotransplantation. 2007;14(5):382.

Farney AC, Singh RP, Moore PS, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux M, Adams PL, Stratta RJ. Does recipient age influence outcomes in pancreatic transplantation? [abstract]. Xenotransplantation. 2007;14(5):522.

Rogers J, Singh R, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Doares W, Ashcraft E, Adams P, Stratta R. Surveillance pancreas biopsies in solitary pancreas transplantation: a shot in the dark? [abstract]. Xenotransplantation. 2007;14(5):413.

Rogers J, Singh RP, Farney AC, Hartmann EL, Reeves-Daniel A, Doares W, Ashcraft E, Adams PL, Stratta RJ. Does pre-transplant C-peptide level determine outcomes in simultaneous kidney-pancreas transplantation? [abstract]. Xenotransplantation. 2007;14(5):528-529.

Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage [abstract]. Xenotransplantation. 2007;14(5):414.

Singh RP, Farney AC, Rogers J, Ashcraft E, Hart L, Doares W, Hartmann EL, Reeves-Daniel A, Adams PL, Stratta RJ. Analysis of bacteremia after pancreas transplantation with enteric drainage [abstract]. Xenotransplantation. 2007;14(5):532.

Moore PS, Farney AC, Hartmann EL, Rogers J, Doares W, Gautreaux MD, Iskandar SS, Hairston G, Adams PL, Stratta RJ. Experience with deceased donor kidney transplantation in 114 patients over age 60. Surgery. 2007;142(4):514-523.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Evolving criteria for accepting deceased donor kidneys for transplantation [abstract]. Transpl Int. 2007;20(Suppl 2):38.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Expanded versus standard criteria donors in kidney transplantation: does age matching make a difference? [abstract]. Transpl Int. 2007;20(Suppl 2):106.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Multivariate analysis of risk factors for graft loss in expanded versus standard criteria deceased donors in kidney transplantation [abstract]. Transpl Int. 2007;20(Suppl 2):244.

Stratta R, Moore P, Farney A, Rogers J, Hartmann E, Gautreaux M, Adams P. Does recipient age make a difference in pancreas transplantation? [abstract]. Transpl Int. 2007;20(Suppl 2):310.

Moore PS, Farney AC, Sundberg AK, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Anderson TK, Adams PL, Stratta RJ, et al. Experience with dual kidney transplants from donors at the extremes of age. Surgery. 2006;140(4):597-606.

Kiger DF, Stratta R, Farney A, Rogers J, Hartmann E, Gautreaux MD. Transplantation may increase risk for Guillain-Barre Syndrome through donor-specific HLA expression [abstract]. Hum Immunol. 2006;67(Suppl 1):S153.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgery, General

Clinical Specialties

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery
Jeffrey Rogers, M.D.

Jeffrey Rogers, M.D.

Professor, Surgery, General
Institute for Regenerative Medicine

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.7
Wait time at clinic
4.4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

6/8/2014

All are excellent care givers !!!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.